Serendipity and VZV drug discovery

Derudas, Marco and McGuigan, Christopher ORCID: https://orcid.org/0000-0001-8409-710X 2012. Serendipity and VZV drug discovery. Drug Discovery Today: Technologies 9 (3) , e177-e181. 10.1016/j.ddtec.2011.11.001

Full text not available from this repository.

Abstract

The discovery of drugs by chance (serendipity) has lead to the development of extremely important drugs in different fields, such as antibiotics, antitumoral and antipsychotic agents to name only a few examples. Recently, serendipity led to the discovery of a new category of compounds extremely active versus chickenpox-shingles (VZV) infections. The lead compound has been further developed and currently has successfully finished phase II clinical trials.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Pharmacy Systems Immunity Research Institute (SIURI)
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Publisher:	Elsevier
ISSN:	1740-6749
Last Modified:	21 Oct 2022 10:49
URI:	https://orca.cardiff.ac.uk/id/eprint/41441

Citation Data

Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item